The upregulation and chronic activation of PERK has been reported in dopaminergic neurons from Parkinson’s patients, in hippocampal neurons in Alzheimer’s brains and in other tauopathies like Progressive Supranuclear Palsy (PSP) [57,58,59,60,61,62]. This evidence concerns the gene EIF2AK3 and Classical progressive supranuclear palsy.